Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.34 |
| ▸ | MME | P08473 | 5/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6009842 | 0.87 | KDM4E (0.40) | TGFBR1OR51E2MMELMNAKDM4E | |
| SCHEMBL6009597 | 0.85 | ITGB1 (0.33) | TGFBR1OR51E2 | |
| SCHEMBL6010454 | 0.84 | FOLH1 (0.46) | — | |
| SCHEMBL6010366 | 0.84 | ALDH1A1 (0.44) | MMELMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL27259500 | 0.84 | TGFBR1 (0.37) | TGFBR1CA2CA1KDM4EMEN1 | |
| SCHEMBL6009547 | 0.83 | FOLH1 (0.44) | — | |
| SCHEMBL6010380 | 0.81 | FOLH1 (0.39) | TGFBR1LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL28491840 | 0.81 | KMT2A (0.38) | TGFBR1CA2CA1LMNAKDM4E | |
| SCHEMBL6010244 | 0.80 | MAPK1 (0.41) | CA2CA1LMNAKDM4EALDH1A1 | |
| SCHEMBL6009533 | 0.80 | FOLH1 (0.44) | CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | TGFBR1 4512/4885OR51E2 2335/4885MME 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.